haNK Archives - Page 3 of 3 - ImmunityBio

Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK

Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK

Oct 17, 2019 | Glioblastoma

Innate and adaptive immunotherapy: An orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T-cell therapy in patients with third line or greater Triple-Negative Breast Cancer (TNBC)

May 26, 2019 | Triple Negative Breast Cancer

CAR-Expressing Natural Killer Cells for Cancer Retargeting

Feb 5, 2019 | Solid Tumors

NANT cancer vaccine an orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with third line or greater metastatic pancreatic cancer.

NANT cancer vaccine an orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with third line or greater metastatic pancreatic cancer.

Jan 29, 2019 | Pancreatic Cancer

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells

Nov 5, 2018 | HIV

Next Entries »